Table 2.
lncRNA | Action | Expression in PMOP | Sources | References |
---|---|---|---|---|
ANCR | inhibit osteoblasts, increase osteoclastogenesis | high | blood mononuclear cells | Wu et al. [9] Cai et al. [55] Tong et al. [56] |
BMNCR | inhibit osteoporosis | low | bone (mouse) | Chen et al. [57] |
CASC11 | lead to TNF-α upregulation in osteoclasts | high | plasma | Yu et al. [58] |
CRNDE | regulate cell apoptosis | high | bone | Li et al. [10] |
GAS5 | regulate osteogenic differentiation | low | bone | Feng et al. [59] |
MALAT1 | unclear | low | bone (mouse) | Yang et al. [60] Zheng et al. [61] |
MEG3 | unclear | high | bone | Wu et al. [9] Wang et al. [62] Sun et al. [63] |
MSC-AS1 | induce osteogenic differentiation | unclear | bone (mouse) | Zhang et al. [64] |
NEF | interact with IL-6 | low | plasma | Ma et al. [65] |
SNHG1 | unclear | low | plasma | Huang et al. [66] |
TUG1 | may promote osteoclast differentiation | high | plasma | Han et al. [67] |
XIXT | promote osteogenic differentiation of BMSCs | low | Serum | Zhang et al. [68] |